Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis

被引:37
作者
Phelps, Jamie P. [1 ]
Dang, Nghiep [1 ]
Rasochova, Lada [1 ]
机构
[1] Dow Chem Co USA, San Diego, CA 92121 USA
关键词
vaccine; plant; chimeric virus-like particles; inactivation; purification;
D O I
10.1016/j.jviromet.2006.12.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Chimeric cowpea mosaic virus (CPMV) particles displaying foreign peptide antigens on the particle surface are suitable for development of peptide-based vaccines. However, commonly used PEG precipitation-based purification methods are not sufficient for production of high quality vaccine candidates because they do not allow for separation of chimeric particles from cleaved contaminating species. Moreover, the purified particles remain infectious to plants. To advance the CPMV technology further, it is necessary to develop efficient and scalable purification strategies and preferably eliminate the infectivity of chimeric viruses. CPMV was engineered to display a 25 amino acid peptide derived from the Bacillus anthracis protective antigen on the surface loop of the large coat protein subunit. The engineered virus was propagated in cowpea plants and assembled into chimeric virus particles displaying 60 copies of the peptide on the surface. An effective inactivation method was developed to produce non-infectious chimeric CPMV virus-like particles (VLPs). Uncleaved VLPs were separated from the contaminating cleaved forms by anion exchange chromatography. The yield of purified chimeric VLPs was 0.3 g kg(-1) of leaf tissue. The results demonstrate the ability to generate multi-gram quantities of non-infectious, chimeric CPMV VLPs in plants for use in the development of peptide-based vaccines. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 30 条
[1]   Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed an a plant virus [J].
Brennan, FR ;
Jones, TD ;
Gilleland, LB ;
Bellaby, T ;
Xu, F ;
North, PC ;
Thompson, A ;
Staczek, J ;
Lin, T ;
Johnson, JE ;
Hamilton, WDO ;
Gilleland, HE .
MICROBIOLOGY-SGM, 1999, 145 :211-220
[2]   Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice [J].
Brennan, FR ;
Bellaby, T ;
Helliwell, SM ;
Jones, TD ;
Kamstrup, S ;
Dalsgaard, K ;
Flock, JI ;
Hamilton, WDO .
JOURNAL OF VIROLOGY, 1999, 73 (02) :930-938
[3]   Cowpea mosaic virus as a vaccine carrier of heterologous antigens [J].
Brennan, FR ;
Jones, TD ;
Hamilton, WDO .
MOLECULAR BIOTECHNOLOGY, 2001, 17 (01) :15-26
[4]   A chimaeric plant virus vaccine protects mice against a bacterial infection [J].
Brennan, FR ;
Gilleland, LB ;
Staczek, J ;
Bendig, MM ;
Hamilton, WDO ;
Gilleland, HE .
MICROBIOLOGY-SGM, 1999, 145 :2061-2067
[5]   Plant-derived vaccine protects target animals against a viral disease [J].
Dalsgaard, K ;
Uttenthal, A ;
Jones, TD ;
Xu, F ;
Merryweather, A ;
Hamilton, WDO ;
Langeveld, JPM ;
Boshuizen, RS ;
Kamstrup, S ;
Lomonossoff, GP ;
Porta, C ;
Vela, C ;
Casal, JI ;
Meloen, RH ;
Rodgers, PB .
NATURE BIOTECHNOLOGY, 1997, 15 (03) :248-252
[6]   Universal influenza A vaccine: Optimization of M2-based constructs [J].
De Filette, M ;
Jou, WM ;
Birkett, A ;
Lyons, K ;
Schultz, B ;
Tonkyro, A ;
Resch, S ;
Fiers, W .
VIROLOGY, 2005, 337 (01) :149-161
[7]  
DIJSTRA J, 1998, PRACTICAL PLANT VIRO
[8]   Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization [J].
Durrani, Z ;
McInerney, TL ;
McLain, L ;
Jones, T ;
Bellaby, T ;
Brennan, FR ;
Dimmock, NJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 220 (1-2) :93-103
[9]  
Elsawa Sherine F, 2004, Expert Rev Vaccines, V3, P563, DOI 10.1586/14760584.3.5.563
[10]   Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines [J].
Ernst, William A. ;
Kim, Hyung J. ;
Tumpey, Terrence M. ;
Jansen, Airan D. A. ;
Tai, Wendy ;
Cramer, Donald V. ;
Adler-Moore, Jill P. ;
Fujii, Gary .
VACCINE, 2006, 24 (24) :5158-5168